Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis
Authors
Keywords
-
Journal
Frontiers in Molecular Neuroscience
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-06-24
DOI
10.3389/fnmol.2014.00057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents
- (2014) Andrew B. West et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Transgenic mice expressing S129 phosphorylation mutations in α-synuclein
- (2014) Valerie Drews Escobar et al. NEUROSCIENCE LETTERS
- Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
- (2014) A. Beilina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
- (2013) Ariadna Recasens et al. ANNALS OF NEUROLOGY
- Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies
- (2013) Paul Davies et al. BIOCHEMICAL JOURNAL
- Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors
- (2013) Simeon Bowers et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PPAR-γ: Therapeutic Prospects in Parkinson's Disease
- (2013) Anna R. Carta CURRENT DRUG TARGETS
- Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP + )-induced cell death via the mitochondrial apoptotic pathway
- (2013) Aifeng Zhai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Adiponectin offers protection against L166P mutant DJ-1-induced neuronal cytotoxicity mediated by APPL1-dependent AMPK activation
- (2013) Xuemei Li et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Beyond the mitochondrion: cytosolic PINK1 remodels dendrites through Protein Kinase A
- (2013) Ruben K. Dagda et al. JOURNAL OF NEUROCHEMISTRY
- Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
- (2013) C. Warren Olanow et al. MOVEMENT DISORDERS
- Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease
- (2013) Fabia Febbraro et al. NEUROBIOLOGY OF DISEASE
- The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro
- (2013) Marija Dulovic et al. NEUROBIOLOGY OF DISEASE
- Celastrol from ‘Thunder God Vine’ Protects SH-SY5Y Cells Through the Preservation of Mitochondrial Function and Inhibition of p38 MAPK in a Rotenone Model of Parkinson’s Disease
- (2013) Bong-Suk Choi et al. NEUROCHEMICAL RESEARCH
- In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain
- (2013) M. Bergeron et al. NEUROSCIENCE
- Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson’s Disease
- (2013) Kang-Woo Lee et al. Neurotherapeutics
- Rotenone Directly Induces BV2 Cell Activation via the p38 MAPK Pathway
- (2013) Feng Gao et al. PLoS One
- Polo-like kinase 2 regulates selective autophagic -synuclein clearance and suppresses its toxicity in vivo
- (2013) A. Oueslati et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson’s disease: a review of in vivo models
- (2013) Hiroyasu Sato et al. REVIEWS IN THE NEUROSCIENCES
- Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice
- (2013) J. A. Moreno et al. Science Translational Medicine
- Pharmacological inhibition of Polo Like Kinase 2 (PLK2) does not cause chromosomal damage or result in the formation of micronuclei
- (2013) Kent Fitzgerald et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Leucine-Rich Repeat Kinase 2 for Beginners: Six Key Questions
- (2013) L. R. Kett et al. Cold Spring Harbor Perspectives in Medicine
- The Role of Autophagy in Parkinson's Disease
- (2013) M. A. Lynch-Day et al. Cold Spring Harbor Perspectives in Medicine
- Parkin- and PINK1-Dependent Mitophagy in Neurons: Will the Real Pathway Please Stand Up?
- (2013) Karl Grenier et al. Frontiers in Neurology
- Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection
- (2013) Jacqueline A. Bayliss et al. Therapeutic Advances in Endocrinology and Metabolism
- PINK1 Deficiency Enhances Inflammatory Cytokine Release from Acutely Prepared Brain Slices
- (2013) Jun Kim et al. Experimental Neurobiology
- Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.
- (2012) J. A. Morales-García et al. ACS Chemical Neuroscience
- Glycogen synthase kinase-3β activation mediates rotenone-induced cytotoxicity with the involvement of microtubule destabilization
- (2012) Haruyuki Hongo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The G2385R variant of leucine-rich repeat kinase 2 associated with Parkinson's disease is a partial loss-of-function mutation
- (2012) Iakov N. Rudenko et al. BIOCHEMICAL JOURNAL
- The GTPase function of LRRK2
- (2012) Jean-Marc Taymans BIOCHEMICAL SOCIETY TRANSACTIONS
- Investigation on PLK2 and PLK3 substrate recognition
- (2012) M. Salvi et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Biochemical Increase in Phosphorylated Alpha-Synuclein Precedes Histopathology of Lewy-Type Synucleinopathies
- (2012) Lih-Fen Lue et al. BRAIN PATHOLOGY
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
- (2012) Douglas G. Walker et al. EXPERIMENTAL NEUROLOGY
- Leucine-rich repeat kinase 2 inhibitors: a patent review (2006 – 2011)
- (2012) Xianming Deng et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein
- (2012) Hyun Jin Cho et al. HUMAN MOLECULAR GENETICS
- Blocking c-Jun N-terminal Kinase (JNK) Translocation to the Mitochondria Prevents 6-Hydroxydopamine-induced Toxicityin Vitroandin Vivo
- (2012) Jeremy W. Chambers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell models
- (2012) Patrícia Silva Guerreiro et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
- (2012) M. S. Moehle et al. JOURNAL OF NEUROSCIENCE
- Tauroursodeoxycholic Acid Prevents MPTP-Induced Dopaminergic Cell Death in a Mouse Model of Parkinson’s Disease
- (2012) M. Castro-Caldas et al. MOLECULAR NEUROBIOLOGY
- Therapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice
- (2012) Kangyong Liu et al. NEUROCHEMICAL RESEARCH
- Large-scale replication and heterogeneity in Parkinson disease genetic loci
- (2012) M. Sharma et al. NEUROLOGY
- Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
- (2012) John M. Kyriakis et al. PHYSIOLOGICAL REVIEWS
- Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
- (2012) Z. Sheng et al. Science Translational Medicine
- G Protein–Coupled Receptor Kinases in Cardiovascular Disease: Why “Where” Matters
- (2012) Fadia A. Kamal et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
- (2012) Christina M. Lill et al. PLoS Genetics
- Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson’s Disease
- (2011) Jeremy W. Chambers et al. ACS Chemical Neuroscience
- Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson’s disease
- (2011) Jinxia Zhou et al. ACTA NEUROPATHOLOGICA
- From Plk1 to Plk5
- (2011) Guillermo de Cárcer et al. CELL CYCLE
- Cyclin-G-associated kinase modifies -synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study
- (2011) A. Dumitriu et al. HUMAN MOLECULAR GENETICS
- A genome-wide association study-derived candidate gene seeks replication: STK39
- (2011) Alexandre Persu et al. JOURNAL OF HYPERTENSION
- Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression
- (2011) G. de Carcer et al. MOLECULAR AND CELLULAR BIOLOGY
- Genetic variability in SNCA and Parkinson’s disease
- (2011) Lasse Pihlstrøm et al. NEUROGENETICS
- LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study
- (2011) S. Sharma et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Potential autophagy enhancers attenuate rotenone-induced toxicity in SH-SY5Y
- (2011) N. Xiong et al. NEUROSCIENCE
- Identification and functional characterization of polo-like kinase 2 autoregulatory sites
- (2011) A.M. Rozeboom et al. NEUROSCIENCE
- Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease
- (2011) Yuncheng Wu et al. NEUROSIGNALS
- G protein-coupled receptor kinases: More than just kinases and not only for GPCRs
- (2011) Eugenia V. Gurevich et al. PHARMACOLOGY & THERAPEUTICS
- LRRK2 Kinase Activity Is Dependent on LRRK2 GTP Binding Capacity but Independent of LRRK2 GTP Binding
- (2011) Jean-Marc Taymans et al. PLoS One
- Neonatal Lethality in Knockout Mice Expressing the Kinase-Dead Form of the Gefitinib Target GAK Is Caused by Pulmonary Dysfunction
- (2011) Hiroe Tabara et al. PLoS One
- Genetic mutations and functions of PINK1
- (2011) Sumihiro Kawajiri et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations
- (2011) H. I. Woodroof et al. Open Biology
- Replication of GWAS Associations for GAK and MAPT in Parkinson's Disease
- (2010) Shannon L. Rhodes et al. ANNALS OF HUMAN GENETICS
- Chaperone-Mediated Autophagy Markers in Parkinson Disease Brains
- (2010) Lydia Alvarez-Erviti et al. ARCHIVES OF NEUROLOGY
- Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
- (2010) Nicolas Dzamko et al. BIOCHEMICAL JOURNAL
- PINK1-linked parkinsonism is associated with Lewy body pathology
- (2010) Lluís Samaranch et al. BRAIN
- SPAK and WNK kinases: a new target for blood pressure treatment?
- (2010) Mark Glover et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia
- (2010) Jonathan Wills et al. EXPERIMENTAL NEUROLOGY
- Casein kinase 1: Complexity in the family
- (2010) Jit Kong Cheong et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
- (2010) Noriyuki Matsuda et al. JOURNAL OF CELL BIOLOGY
- LRRK2 Is Involved in the IFN- Response and Host Response to Pathogens
- (2010) A. Gardet et al. JOURNAL OF IMMUNOLOGY
- Characterization of kinases involved in the phosphorylation of aggregated α-synuclein
- (2010) Elisa A. Waxman et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Kinase regulation of Na+-K+-2Cl−cotransport in primary afferent neurons
- (2010) Eric Delpire et al. JOURNAL OF PHYSIOLOGY-LONDON
- Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases
- (2010) Daniel I. Perez et al. MEDICINAL RESEARCH REVIEWS
- Who was the man who discovered the “Lewy bodies”?
- (2010) Antonio M. Rodrigues e Silva et al. MOVEMENT DISORDERS
- Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
- (2010) Leslie Crews et al. PLoS One
- PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
- (2010) Derek P. Narendra et al. PLOS BIOLOGY
- Lrrk2 interaction with α-synuclein in diffuse Lewy body disease
- (2009) Hong Qing et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Contribution of endogenous G-protein-coupled receptor kinases to Ser129 phosphorylation of α-synuclein in HEK293 cells
- (2009) Masahiro Sakamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- G protein-coupled receptor kinase 5, overexpressed in the α-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression
- (2009) Peng Liu et al. BRAIN RESEARCH
- Molecular pathogenesis of Parkinson disease: insights from genetic studies
- (2009) Thomas Gasser EXPERT REVIEWS IN MOLECULAR MEDICINE
- LRRK2gene variation and its contribution to Parkinson disease
- (2009) Coro Paisán-Ruiz HUMAN MUTATION
- Phosphorylation of Synucleins by Members of the Polo-like Kinase Family
- (2009) Martial K. Mbefo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Leucine-Rich Repeat Kinase 2 Expression Leads to Aggresome Formation That Is Not Associated With α-Synuclein Inclusions
- (2009) Elisa A. Waxman et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- α-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease
- (2009) Nikolaus R. McFarland et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation
- (2009) C. Malagelada et al. JOURNAL OF NEUROSCIENCE
- Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in -Synuclein Models of Parkinson's and Lewy Body Diseases
- (2009) B. Spencer et al. JOURNAL OF NEUROSCIENCE
- JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease
- (2009) Yongsheng Wang et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
- (2009) Wataru Satake et al. NATURE GENETICS
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Alterations in lysosomal and proteasomal markers in Parkinson's disease: Relationship to alpha-synuclein inclusions
- (2009) Yaping Chu et al. NEUROBIOLOGY OF DISEASE
- Rapamycin protects against rotenone-induced apoptosis through autophagy induction
- (2009) T. Pan et al. NEUROSCIENCE
- Akt signal transduction dysfunction in Parkinson's disease
- (2009) Suzanne Timmons et al. NEUROSCIENCE LETTERS
- The progression of pathology in longitudinally followed patients with Parkinson’s disease
- (2008) Glenda Halliday et al. ACTA NEUROPATHOLOGICA
- Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity
- (2008) Christopher J. Yuskaitis et al. CELLULAR SIGNALLING
- Genomewide association study for susceptibility genes contributing to familial Parkinson disease
- (2008) Nathan Pankratz et al. HUMAN GENETICS
- Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
- (2008) Kelly J. Inglis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway
- (2008) C. Richardson et al. JOURNAL OF CELL SCIENCE
- MAPKAP kinase 2-deficiency prevents neurons from cell death by reducing neuroinflammation – relevance in a mouse model of Parkinson’s disease
- (2008) Tobias Thomas et al. JOURNAL OF NEUROCHEMISTRY
- Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of ??-Synuclein
- (2008) Elisa A. Waxman et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- Glycogen synthase kinase-3beta is associated with Parkinson's disease
- (2008) Masahiro Nagao et al. NEUROSCIENCE LETTERS
- Whole-genome association study identifies STK39 as a hypertension susceptibility gene
- (2008) Y. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Localization of CKII β subunits in Lewy bodies of Parkinson's disease
- (2007) Myung Yi Ryu et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease
- (2007) J. Alegre-Abarrategui et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia
- (2006) E.R. Bychkov et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started